Latest News & Features
article
The US District Court for the District of Arizona has rejected technology company W.L. Gore’s motion for a new trial to amend the judgment of its patent dispute with medical device maker C.R. Bard. 24 October 2013
article
British barrister Richard Hacon is set to become the permanent presiding judge of the Intellectual Property Enterprise Court, multiple sources have told WIPR. 22 October 2013
Big Pharma
UK-based pharmaceutical company AstraZeneca announced on October 15 that its biologics R&D subsidiary MedImmune had acquired cancer drug maker Spirogen. 18 October 2013
article
The US Court of Appeals for the Federal Circuit has denied a US company’s bid to trademark “Prevail” for medical devices used to treat obesity. 16 October 2013
Americas
New guidelines for the examination of biotechnology inventions in Brazil provide useful support for applicants, as Gabriel Di Blasi and Alexandre Santos explain. 16 October 2013
Biotechnology
Frances Salisbury and Lindsey Woolley look at the complex business of patenting agricultural products in Europe. 16 October 2013
Americas
In the life sciences sector, defending broad patent claims can be a tricky business, says Gordon Wright. 16 October 2013
Biotechnology
The Court of Justice of the European Union’s decision in the Brüstle case has worrying implications for some stem cell patents. Andy Sanderson looks at the landscape across Europe. 16 October 2013
Asia
Many of the world’s biggest selling drugs have lost exclusivity in recent years, presenting huge opportunities for generic drugs companies but, as LSIPR finds out, it doesn’t have to be a dead end for the innovators. 16 October 2013
Biotechnology
When the US Supreme Court decided in favour of Monsanto in its case against a soybean farmer, it clarified the patent status of certain self-replicating technologies. In Europe, the result would probably have been the same, say Steven Zeman and Heike Vogelsang-Wenke. 16 October 2013